1 to 16

Name Sector Revenue
$mlns  
M&A Activity Last 5 Years
Total Buy Sell
Roche
SIX Swiss Exchange : RHHBY
Basel, Switzerland website
Life Science 64,831 46 44 2
Merck
NYSE : MRK
Rahway, New Jersey, United States website
Life Science 64,168 44 37 7
Pfizer
NYSE : PFE
New York, New York, United States website
Life Science 63,627 64 45 19
AbbVie
NYSE : ABBV
North Chicago, Illinois, United States website
Life Science 56,334 16 15 1
AstraZeneca
NASDAQ : AZN
Cambridge, United Kingdom website
Life Science 54,073 34 23 11
Bayer
Frankfurt (FWB) : BAYN
Leverkusen, Germany website
Life Science 52,520 43 20 23
Novartis
NYSE : NVS
Basel, Switzerland website
Life Science 51,772 44 36 8
Sanofi
NASDAQ : SNY
Paris, France website
Life Science 49,906 45 30 15
GSK
London Stock Exchange : GSK
Brentford, United Kingdom website
Life Science 48,300 59 35 24
Bristol-Myers Squibb
NYSE : BMY
Princeton, New Jersey, United States website
Life Science 48,300 38 25 13
Lilly
NYSE : LLY
Indianapolis, Indiana, United States website
Life Science 45,043 48 38 10
Novo Nordisk
NYSE : NVO
Bagsvaerd, Denmark website
Life Science 43,808 9 9 -
Shanghai Pharma
Shanghai (SSE) : 601607
Shanghai, China website
Life Science 43,195 1 1 -
Takeda
Tokyo (TSE) : 4502
Tokyo, Japan website
Life Science 37,921 24 18 6
Amgen
NASDAQ : AMGN
Thousand Oaks, California, United States website
Life Science 33,424 21 21 -
Gilead Sciences
NASDAQ : GILD
Foster City, California, United States website
Life Science 28,754 27 24 3

Try Mergr Free — Access the Full List Today

Find the Right Companies Fast.
Get Full Access. Cancel Anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr was built to make it easy to understand who owns which companies — and how they got there.

Whether you're researching private equity-backed businesses, recent acquisitions, or potential targets, Mergr provides structured access to thousands of companies, investors, and ownership histories.

The platform is powerful but easy to use — so you can quickly surface relevant companies and move from research to action.

Mergr, the Easiest-to-Use PE
and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.